| Market Capitalization (Millions $) |
2,264 |
| Shares
Outstanding (Millions) |
545 |
| Employees |
724 |
| Revenues (TTM) (Millions $) |
2,477 |
| Net Income (TTM) (Millions $) |
-18 |
| Cash Flow (TTM) (Millions $) |
-15 |
| Capital Exp. (TTM) (Millions $) |
2 |
Business Description
Clover Health Investments Corp is a healthcare company that specializes in Medicare Advantage plans. The company was founded in 2014 by Vivek Garipalli and Kris Gale, with the aim of using technology to improve healthcare outcomes for seniors.
Clover Health has a unique approach to healthcare that leverages data analytics and machine learning algorithms to identify patients that may require additional care, and proactively intervenes to prevent health issues from developing. Clover Health's focus on preventative care and disease management has allowed the company to deliver better healthcare outcomes at a lower cost than traditional Medicare plans.
Clover Health's Medicare Advantage plans offer a range of benefits, including hospitalization, doctor visits, lab tests, and prescription drugs. The plans also include additional benefits such as vision, dental, and hearing coverage, as well as fitness and wellness programs.
In 2021, Clover Health went public through a merger with a special purpose acquisition company (SPAC) called Social Capital Hedosophia Holdings Corp III. The company trades on the NASDAQ under the ticker symbol CLOV.
Clover Health has faced some criticism in recent years, particularly around allegations of fraud and misleading marketing practices. The company has also come under scrutiny for its relationship with its largest investor, venture capital firm Chamath Palihapitiya.
Despite these issues, Clover Health remains a significant player in the Medicare Advantage market, with a growing customer base and a commitment to improving healthcare outcomes for seniors through the use of technology and innovation.
Company Address: 3401 Mallory Lane Franklin 37067 TN
Company Phone Number: 432-2133 Stock Exchange / Ticker: NASDAQ CLOV
|
17.29% 
6.14 %